HANNAH CASE: Open Payments
NPI 1033824792 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 8 payments from 8 companies in 2025. Trend: 2023 $152 · 2024 $223 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $20 |
| Kite Pharma, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Abbott Laboratories | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: PLUVICTO, TECVAYLI, Yescarta, Lenvima, LYNPARZA, ELREXFIO.
Industry payments across TN — which companies pay providers there.
